首页> 外文期刊>Langenbeck's archives of surgery >Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer.
【24h】

Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer.

机译:胃癌同步性肝转移的预后因素分析和手术治疗评价。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIMS: Whether or not a synchronous resection of liver metastases from gastric cancer provides a survival benefit has been a key issue. We identify the significant prognostic factors and clarify the beneficial effect on the survival of liver surgical treatment. MATERIALS AND METHODS: We reviewed 72 patients who underwent a gastrectomy for gastric cancer with synchronous liver metastases and classified the liver metastases into three grades, such as H1: metastases were limited to one of the lobes, H2: there were a few scattered metastases in both lobes, and H3: there were numerous scattered metastases. RESULTS: H1, 2 metastases, and an absence of peritoneal dissemination (P0) were significantly independent prognostic factors for liver metastases of gastric cancer. In addition, the cumulative 1 and 5-year survival rates of liver surgical treatment (hepatic resection and/or microwave coagulation therapy) were 80.0% and 60.0%, whereas the survival rates for non-hepatic surgical treatment were 36.4% and 0% in 26 patients with H1, 2, and P0. In those patients, the radical operation, the solitary metastatic liver tumor, and no-distant lymph node metastases were independent prognostic determinants of survival. CONCLUSION: The radical operation including the surgical treatment for metastatic liver tumors should be performed to improve the prognosis in gastric cancer patients with synchronous H1, 2, and P0.
机译:背景与目的:胃癌肝转移的同步切除是否能提供生存益处已成为关键问题。我们确定了重要的预后因素,并阐明了对肝脏手术治疗生存的有利影响。材料与方法:我们回顾了72例因胃癌同步切除而接受胃切除术的胃癌患者,并将肝转移分为三个等级,例如H1:转移仅限于其中一个肺叶; H2:有少量散在转移两个叶和H3:有许多分散的转移灶。结果:H1,2转移和缺乏腹膜扩散(P0)是胃癌肝转移的独立预后因素。此外,肝手术治疗(肝切除和/或微波凝固疗法)的1年和5年累积生存率分别为80.0%和60.0%,而非肝手术治疗的生存期分别为36.4%和0%。 26名H1、2和P0患者。在这些患者中,根治性手术,孤立性转移性肝肿瘤和无远处淋巴结转移是生存的独立预后决定因素。结论:对于H1、2和P0同时发生的胃癌患者,应行根治性手术,包括手术治疗转移性肝肿瘤,以改善预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号